Israeli data shows Pfizer vaccine nearly 99 percent effective at preventing COVID-19 death 2 weeks after 2nd dose


More good news came out of Israel on Saturday when the country's health ministry released another round of data on the Pfizer-BioNTech COVID-19 vaccine, further affirming its effectiveness.
The latest numbers, which were compiled through Feb. 13 and compare the vaccinated and unvaccinated populations, show that the jab has been nearly 96 percent effective at preventing symptomatic COVID-19 infections two weeks after individuals receive their second dose. When it comes to preventing severe infections, hospitalizations, and deaths from the coronavirus, the figure jumps to an efficacy rate around 99 percent.
Israel has emerged as the world's clearest case study for determining whether the Pfizer vaccine works, since the country has the highest vaccination rate in the world. So far, the data has been consistently promising, though the situation is still fluid and under observation.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
Does Reform have a Russia problem?
Talking Point Nigel Farage is ‘in bed with Putin’, claims Rachel Reeves, after party’s former leader in Wales pleaded guilty to taking bribes from the Kremlin
-
Five key questions about the Gaza peace deal
The Explainer Many ‘unresolved hurdles’ remain before Donald Trump’s 20-point plan can get the go-ahead
-
See the Northern Lights from these bucket list destinations
The Week Recommends The dazzling displays can be spotted across Iceland, Sweden and parts of Canada
-
FDA OKs generic abortion pill, riling the right
Speed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
RFK Jr. vaccine panel advises restricting MMRV shot
Speed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreak
Speed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agency
Speed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year high
Speed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials